At ArchiMed, we are committed to sustainability. We are convinced that economic actors have the duty to actively contribute to providing sustainable and life-changing solutions.
As market-leading impact investors in the healthcare industry, our first and foremost goal is to help small and medium companies develop their activities and achieve their role as solution providers to improve human / animal health conditions.
We believe this is fully compatible and synergistic with providing positive returns to our clients.
Following the implementation of the EU’s Sustainable Finance Disclosure Registration (SFDR) regulations, ArchiMed has categorized the Funds as financial products that promote environmental or social characteristics (Article 8 of the SFDR Regulation).
The sustainability risk policy of ArchiMed and the remuneration policy are available to the investors on the Investor Portal.